Atlas Trials

Agaricus Blazei Murill (ABM) in Patients With Inflammatory Bowel Disease (IBD)

Clinical trial NCT01106742 · COMPLETED

Trial details

NCT number
NCT01106742
Sponsor
Ullevaal University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Inflammatory Bowel Disease
Start date
2009-03-01
Primary completion
2011-07-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.